| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/12/2011 | US20110112148 Indoline compounds |
| 05/12/2011 | US20110112147 Indazolone analogs as glycogen synthase activators |
| 05/12/2011 | US20110112143 Allosteric modulators of metabotropic glutamate receptors |
| 05/12/2011 | US20110112139 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/12/2011 | US20110112130 Opioid-Nornicotine Codrugs Combinations for Pain Management |
| 05/12/2011 | US20110112127 Compounds and methods for kinase modulation, and indications therefor |
| 05/12/2011 | US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy |
| 05/12/2011 | US20110112108 Pyridazine fungicides |
| 05/12/2011 | US20110112103 5-hydroxypyrimidine-4-carboxamide compound |
| 05/12/2011 | US20110112097 Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 05/12/2011 | US20110112096 Pyrimidine derivatives as kinase inhibitors |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112091 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a methof of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 05/12/2011 | US20110112088 Pyrazoles for the treatment of obesity and other cns disorders |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/12/2011 | US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 05/12/2011 | US20110112071 Novel heterocyclidene acetamide derivative |
| 05/12/2011 | US20110112070 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
| 05/12/2011 | US20110112067 Inhibitors of the Human Aldosterone Sythase CYP11B2 |
| 05/12/2011 | US20110112063 Pyrimidine derivatives as kinase inhibitors |
| 05/12/2011 | US20110112060 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110112051 Dipeptidyl Peptidase-IV Inhibitors |
| 05/12/2011 | US20110111519 Reagent for detecting an analyte |
| 05/12/2011 | US20110111510 Methods to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test |
| 05/12/2011 | US20110111162 Indolium compound and optical recording material containing the same |
| 05/12/2011 | US20110111046 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 05/12/2011 | US20110110961 Prolyl hydroxylase inhibitors |
| 05/12/2011 | US20110110889 Raf inhibitor compounds and methods of use thereof |
| 05/12/2011 | US20110110865 Chelatros, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 05/12/2011 | US20110110850 Compounds for therapy and diagnosis |
| 05/12/2011 | US20110108826 Anthracene derivative and an organic electronic device using the same |
| 05/12/2011 | US20110108823 Materials for organic electroluminescence devices |
| 05/12/2011 | DE102009053191A1 Materialien für elektronische Vorrichtungen Materials for electronic devices |
| 05/12/2011 | CA2780428A1 Tablet formulations of neratinib maleate |
| 05/12/2011 | CA2780149A1 Ire-1.alpha. inhibitors |
| 05/12/2011 | CA2780128A1 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 05/12/2011 | CA2780111A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 05/12/2011 | CA2779989A1 Quinazoline compounds |
| 05/12/2011 | CA2778922A1 Process for the preparation of pyrazinone thrombin inhibitor and its intermediates |
| 05/12/2011 | CA2778161A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 05/12/2011 | CA2778115A1 Imidazole derivatives as ido inhibitors |
| 05/11/2011 | EP2319890A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
| 05/11/2011 | EP2319843A1 Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
| 05/11/2011 | EP2319842A1 Fluorescent carbazole compounds for cancer diagnosis |
| 05/11/2011 | EP2319841A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 05/11/2011 | EP2319837A1 Benzimidazole derivatives and their use for modulating the GABAa receptor complex |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2318406A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 05/11/2011 | EP2318392A2 Pyrimidine derivatives as kinase inhibitors |
| 05/11/2011 | EP2318391A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
| 05/11/2011 | EP2318390A1 Pyrrole compounds |
| 05/11/2011 | EP2318389A1 Pyridazine derivatives as smo inhibitors |
| 05/11/2011 | EP2318388A2 Tricyclic spirocycle derivatives and methods of use thereof |
| 05/11/2011 | EP2318387A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 05/11/2011 | EP2318378A2 Quinazoline derivatives |
| 05/11/2011 | EP2318376A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors |
| 05/11/2011 | EP2318374A2 Insecticidal benzenedicarboxamide derivative |
| 05/11/2011 | EP2318370A1 Fluorinated heteroaryls |
| 05/11/2011 | EP2318369A1 Squaric acid derivatives as inhibitors of the nicotinamide |
| 05/11/2011 | EP2318367A1 Piperidine and pyrrolidine compounds |
| 05/11/2011 | EP2318363A1 Heterocyclic derivatives as iap binding compounds |
| 05/11/2011 | EP2318006A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/11/2011 | EP2317849A1 Method for treating pulmonary diseases using rho kinase inhibitor compounds |
| 05/11/2011 | EP2220053B1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 05/11/2011 | EP2042171B1 Therapeutic or prophylactic agent for allergic dermatitis |
| 05/11/2011 | EP1763517B1 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 05/11/2011 | EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/11/2011 | EP1320520B1 Sulfonylguanidine |
| 05/11/2011 | CN1845917B 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicament |
| 05/11/2011 | CN102056920A Tetrazole compounds as orexin receptor antagonists |
| 05/11/2011 | CN102056919A Substituted sulfonamide derivatives |
| 05/11/2011 | CN102056918A Pyrrolidine ether derivatives as NK3 receptor antagonists |
| 05/11/2011 | CN102056917A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 05/11/2011 | CN102056916A Novel heteroaromatic amides and thioamides as pesticides |
| 05/11/2011 | CN102056915A 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides |
| 05/11/2011 | CN102056905A Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof |
| 05/11/2011 | CN102056902A Imidazolidine derivatives |
| 05/11/2011 | CN102056900A Compounds and compositions as modulators of GPR119 activity |
| 05/11/2011 | CN102056894A Homocysteine synthase inhibitor |
| 05/11/2011 | CN102050815A Dabigatran ester derivatives as prodrug |
| 05/11/2011 | CN102050814A Ester derivatives of dabigatran |
| 05/11/2011 | CN102050813A Fluorescence quencher molecules, and method and use thereof |
| 05/11/2011 | CN102050794A Quinoxalin derivative and organic LED (Light-Emitting Diode) containing same |
| 05/11/2011 | CN102050793A 4(3H) quinazolinone derivatives with antitumor activity |
| 05/11/2011 | CN102050780A Quinoline derivatives, and medicament composition and application thereof |
| 05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
| 05/11/2011 | CN101684088B Cyanomethyl pyrrole derivative and preparation method and application thereof |
| 05/11/2011 | CN101238135B Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 05/11/2011 | CN101121695B Method for preparing nitrogen-containing onium salt compounds |
| 05/11/2011 | CN101072561B Diaminoalkane aspartic protease inhibitors |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7939657 N-substituted benzene sulfonamides |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | US7939548 Certain chemical entities, compositions, and methods |
| 05/10/2011 | US7939541 Condensing (3-trifluoromethylsulfonyl) benzoyl chloride and 4-methyl-2-nitro-aniline; reducing nitro group with stannous chloride; condensing amino group with cyanamide; cyclocondensing guanidine group with 3-dimethylamino-1-pyridin-3-yl-propenone; antiproliferative agent |
| 05/10/2011 | US7939539 Quinazolinone compounds as anticancer agents |
| 05/10/2011 | US7939534 Certain chemical entities, compositions, and methods |